Bowry T R, Muturi I L, Radia R, Gitau W
J Clin Lab Immunol. 1984 Nov;15(3):133-6.
A controlled prospective study of autoantibody profile on black Kenyan patients with non-toxic goitre (116), thyrotoxicosis (131) and age, sex matched hospital controls is reported. The prevalence of thyroid microsomal and thyroglobulin antibodies is 3.5% in smooth non-toxic goitre and is 5.2% in the nodular non-toxic goitre compared to 1% of the control. The results reflect that autoimmune thyroiditis is less common in Kenyan hospital controls and smooth simple goitre which is even more pronounced in case of multinodular simple goitre as compared to the Caucasians. The prevalence of microsomal antibody of 54% and the occurrence of high titres in 19% of the toxic group is relatively similar in Caucasians and black Kenyans. However, thyroglobulin antibody and parietal cell antibody are far less frequent in the Kenyan toxic group as compared to Caucasians. In conclusion, the black Kenyan toxic cases are reluctant to produce thyroglobulin and parietal cell antibodies while microsomal antibody production is unaffected. The latter is thought to be more significant in the development and progression of autoimmune thyroiditis. The dissociated behaviour of the two thyroid specific antibodies and thyrogastric axis in black Kenyans strongly suggest that the immunogenetic control of these and the related diseases is different in them as compared to the Caucasians.
报告了一项针对肯尼亚黑人非毒性甲状腺肿患者(116例)、甲状腺毒症患者(131例)以及年龄和性别匹配的医院对照人群自身抗体谱的对照前瞻性研究。甲状腺微粒体抗体和甲状腺球蛋白抗体在平滑型非毒性甲状腺肿中的患病率为3.5%,在结节型非毒性甲状腺肿中为5.2%,而对照组为1%。结果表明,自身免疫性甲状腺炎在肯尼亚医院对照人群中不太常见,在平滑型单纯性甲状腺肿中更为明显,与多结节型单纯性甲状腺肿相比,在白种人中更为显著。毒性组中微粒体抗体患病率为54%,19%出现高滴度,在白种人和肯尼亚黑人中相对相似。然而,与白种人相比,肯尼亚毒性组中甲状腺球蛋白抗体和壁细胞抗体的出现频率要低得多。总之,肯尼亚黑人毒性病例不太容易产生甲状腺球蛋白和壁细胞抗体,而微粒体抗体的产生不受影响。后者被认为在自身免疫性甲状腺炎的发生和发展中更为重要。肯尼亚黑人中两种甲状腺特异性抗体和甲状腺胃轴的分离行为强烈表明,与白种人相比,他们对这些疾病及相关疾病的免疫遗传控制有所不同。